Abstract
Background: Breast cancer mortality rates in women have been declining at the same time as breast cancer incidence rates, mammography rates and use of effective adjuvant therapy have been increasing. The objective of this study was to examine population data on breast cancer screening and breast cancer mortality to see if there is any geographic association between mammographic screening and breast cancer mortality reduction in the US, after adjusting for therapy use.
Methods: Regression analysis of the estimated annual percent reduction of breast cancer mortality was performed on mammography use from the Behavioral Risk Factors Surveillance System (BRFSS) at state level. A secondary regression analysis on the SEER-11 region, at an aggregated Health Services Area (HSA) level, was carried out to adjust for use of adjuvant therapy. The annual percent change in the incidence of early stage cancer, calculated from SEER cancer data was used as a surrogate for mammography use. Adjuvant therapy use was estimated from SEER data and adjusted using the Patterns of Care data.
Results: All the analyses showed a small but significant negative correlation between mammography usage and mortality reduction (correlation of −0.285, p-value 0.045) in breast cancer (state level) and change in ‘early’ stage breast cancer and mortality reduction (at HSA level) unadjusted (correlation of −0.307, p-value 0.065) and adjusted (partial correlation of −0.337, p-value 0.044) for adjuvant therapy use.
Discussion: The results of the two analyses appear to show a moderate effect of mammography usage on decreasing breast cancer mortality in the US, which seems to support the conclusions of randomized mammographic screening trials. While randomized controlled trials are certainly the gold standard in appraising the efficacy of new screening or treatment modalities, such trials are conducted under standardized conditions and do not always reflect the effect of these interventions at population level. This paper attempts to examine population level effects through ecologic analyses. Results, however, need to be interpreted cautiously owing to the limitations and biases inherent in such analyses.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
O Olsen P Gotzsche (2001) ArticleTitleCochrane review on screening for breast cancer with mammography Lancet 358 1340–1342 Occurrence Handle10.1016/S0140-6736(01)06449-2 Occurrence Handle11684218
PC Gotzsche O Olsen (2000) ArticleTitleIs screening for breast cancer with mammography justifiable? Lancet 355 129–134 Occurrence Handle10.1016/S0140-6736(99)06065-1 Occurrence Handle10675181
InstitutionalAuthorNameCorrespondence (2000) ArticleTitleScreening mammography re-evaluated Lancet 355 747–748
HJ De Koning (2000) ArticleTitleAssessment of nationwide cancer-screening programmes Lancet 355 80–81 Occurrence Handle10.1016/S0140-6736(99)00419-5 Occurrence Handle10675158
L Nystrom I Andersson N Bjurstam J Frisell B Nordenskjold LE Rutqvist (2002) ArticleTitleLong-term effects of mammography screening: updated overview of the Swedish randomized trials Lancet 359 909–919 Occurrence Handle10.1016/S0140-6736(02)08020-0 Occurrence Handle11918907
OS Miettinen CI Henschke MW Pasmantier JP Smith DM Libby DF Yankelevitz (2002) ArticleTitleMammographic screening: no reliable supporting evidence. Lancet 359 404–405 Occurrence Handle10.1016/S0140-6736(02)07592-X Occurrence Handle11844515
LL Humphrey M Helfand BKS Chan SH Woolf (2002) ArticleTitleBreast Cancer Screening: a summary of the evidence for the U.S. Preventive Services Task Force Ann Intern Med 137 347–360 Occurrence Handle12204020
Screening for Breast Cancer: Recommendations and rationale (2002) Agency for Healthcare Research and Quality, Rockville, MD. Available from http://www.ahrq.gov/clinic/3rduspstf/breastcancer/brcanrr.htm
L Tabar CJ Fagerberg A Gad et al. (1985) ArticleTitleReduction in mortality from breast cancer after mass screening with mammography. Randomised trial from the Breast Cancer Screening Working Group of the Swedish National Board of Health and Welfare Lancet 1 829–832 Occurrence Handle10.1016/S0140-6736(85)92204-4 Occurrence Handle2858707
I Andersson L Janzon (1997) ArticleTitleReduced breast cancer mortality in women under age 50: updated results from the Malmo Mammographic Screening Program J Natl Cancer Inst Monogr 22 63–67 Occurrence Handle9709278
FE Alexander TJ Anderson HK Brown et al. (1999) ArticleTitle14 years of follow-up from the Edinburgh randomized trial of breast-cancer screening Lancet 353 1903–1908 Occurrence Handle10.1016/S0140-6736(98)07413-3 Occurrence Handle10371567
K Kerlikowske D Grady SM Rubin C Sandrock VL Ernster (1995) ArticleTitleEfficacy of screening mammography. A meta-analysis JAMA 273 149–154 Occurrence Handle10.1001/jama.273.2.149 Occurrence Handle7799496
S Shapiro W Venet P Strax L Venet R Roeser (1982) ArticleTitleTen- to fourteen-year effect of screening on breast cancer mortality J Natl Cancer Inst 69 349–355 Occurrence Handle6955542
N Breen DK Wagener M Brown WW Davis R Ballard-Barbash (2001) ArticleTitleProgress in cancer screening over a decade: results of cancer screening from the 1987, 1992, and 1998 National Health Interview Surveys J Natl Cancer Inst 93 1704–1713 Occurrence Handle10.1093/jnci/93.22.1704 Occurrence Handle11717331
A Mariotto EJ Feuer LC Harlan LM Wun KA Johnson J Abrams (2002) ArticleTitleTrends in use of adjuvant multi-agent chemotherapy and tamoxifen for breast cancer in the United States: 1975–1999 J Natl Cancer Inst 94 1626–1634 Occurrence Handle12419789
DM Makuc B Haglund DD Ingram JC Kleinman JJ Feldman (1991) ArticleTitleHealth Service areas for the United States Vital Health Stat 2 1–102
GW Snedecor WG Cochran (1972) Statistical Methods EditionNumber6 Iowa State University Press Ames, IA 393–398
JL Warren LC Harlan (2003) ArticleTitleCan cancer registry data be used to study cancer treatment? Med Care 41 1003–1005 Occurrence Handle10.1097/01.MLR.0000086827.00805.B5 Occurrence Handle12972839
LC Harlan LX Clegg JL Warren (2003) ArticleTitleChemotherapy in women with breast cancer Ann Intern Med 139 868 Occurrence Handle14623632
National Cancer Institute Breast Cancer Surveillance Consortium: Evaluating Screening Performance in Practice (2004). NIH Publication No. 04-5490. Bethesda, MD: National Cancer Institute, National Institutes of Health, U.S. Department of Health and Human Services. Available at: http://breastscreening.cancer. gov/espp.pdf, pp. 24–25
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Das, B., Feuer, E.J. & Mariotto, A. Geographic association between mammography use and mortality reduction in the US. Cancer Causes Control 16, 691–699 (2005). https://doi.org/10.1007/s10552-005-1991-x
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/s10552-005-1991-x